215 related articles for article (PubMed ID: 10824041)
1. Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae.
Morrissey I; George JT
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():107-10. PubMed ID: 10824041
[TBL] [Abstract][Full Text] [Related]
2. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
Davies TA; Kelly LM; Pankuch GA; Credito KL; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
[TBL] [Abstract][Full Text] [Related]
3. Differences between two new quinolones (gemifloxacin and trovafloxacin) and ciprofloxacin in their concentration-dependent killing of Streptococcus pneumoniae.
Joyanes P; Pascual A; Giménez MJ; García I; Aguilar L; Perea E
Chemotherapy; 2001 Dec; 47(6):409-14. PubMed ID: 11786655
[TBL] [Abstract][Full Text] [Related]
4. Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers.
Prieto J; Aguilar L; Fuentes F; Giménez MJ; Alou L; Dal-Ré R; Sörgel F; Frías J
Int J Antimicrob Agents; 2001 Sep; 18(3):231-8. PubMed ID: 11673035
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin.
Fuentes F; Giménez MJ; Marco F; Alou L; Aguilar L; Prieto J
Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):137-9. PubMed ID: 10746503
[TBL] [Abstract][Full Text] [Related]
6. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
[TBL] [Abstract][Full Text] [Related]
7. The bactericidal activity of gemifloxacin (SB-265805).
Morrissey I; Clark S; Mathias I
J Med Microbiol; 2000 Sep; 49(9):841-844. PubMed ID: 10966234
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens.
Rittenhouse S; McCloskey L; Broskey J; Niconovich N; Jakielaszek C; Poupard J; Coleman K
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():23-7. PubMed ID: 10824028
[TBL] [Abstract][Full Text] [Related]
9. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
10. Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones.
Morrissey I; George JT
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():101-6. PubMed ID: 10824040
[TBL] [Abstract][Full Text] [Related]
11. Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin, levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin.
Evans ME
Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):883-5. PubMed ID: 11837640
[TBL] [Abstract][Full Text] [Related]
12. Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.
Nagai K; Davies TA; Dewasse BE; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 2001 Sep; 48(3):365-74. PubMed ID: 11533001
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
Zhanel GG; Roberts D; Waltky A; Laing N; Nichol K; Smith H; Noreddin A; Bellyou T; Hoban DJ
J Antimicrob Chemother; 2002 May; 49(5):807-12. PubMed ID: 12003975
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae.
Kerawala M; Ambler JE; Lee PY; Drabu YJ
Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):271-5. PubMed ID: 11399019
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
García-Olmos M; Parra A; García-Calvo G; Ponte C; Giménez MJ; Aguilar L; Soriano F
Int J Antimicrob Agents; 2003 Jun; 21(6):568-73. PubMed ID: 12791471
[TBL] [Abstract][Full Text] [Related]
16. Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones.
Yague G; Morris JE; Pan XS; Gould KA; Fisher LM
Antimicrob Agents Chemother; 2002 Feb; 46(2):413-9. PubMed ID: 11796351
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of gemifloxacin.
King A; May J; French G; Phillips I
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():1-12. PubMed ID: 10824026
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens.
García-Garrote F; Cercenado E; Martín-Pedroviejo J; Cuevas O; Bouza E
J Antimicrob Chemother; 2001 May; 47(5):681-4. PubMed ID: 11328784
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae.
Calvo A; Giménez MJ; Alou L; Gómez-Lus ML; Aguilar L; Prieto J
Int J Antimicrob Agents; 2002 Aug; 20(2):144-6. PubMed ID: 12297365
[No Abstract] [Full Text] [Related]
20. Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms.
Heaton VJ; Goldsmith CE; Ambler JE; Fisher LM
Antimicrob Agents Chemother; 1999 Dec; 43(12):2998-3000. PubMed ID: 10582896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
